Selected research
Market Structure
Global Steroids Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Steroids market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Steroids is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Steroids is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Steroids is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Steroids is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Steroids include Zizhu Pharma, Sanofi, Novartis, Merck, Pfizer, GSK, Bayer, AstraZeneca and Sumitomo, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Steroids market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Steroids and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Steroids sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Steroids market size, projected growth trends, production technologies, key applications, and end-use industries.
Steroids Segment by Company
Zizhu Pharma
Sanofi
Novartis
Merck
Pfizer
GSK
Bayer
AstraZeneca
Sumitomo
Cipla
Steroids Segment by Type
Corticosteroids
Sex Hormones
Steroids Segment by Application
Injection
Inhalation
Oral
Topical
Steroids Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Steroids market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Steroids and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Steroids.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Steroids market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Steroids manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Steroids in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Steroids in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Corticosteroids
- Sex Hormones
Applications
- Injection
- Inhalation
- Oral
- Topical
Companies covered
- Zizhu Pharma
- Sanofi
- Novartis
- Merck
- Pfizer
- GSK
- Bayer
- AstraZeneca
- Sumitomo
- Cipla
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Steroids Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Steroids Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Steroids Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Steroids Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Steroids Market Dynamics
- 2.1 Steroids Industry Trends
- 2.2 Steroids Industry Drivers
- 2.3 Steroids Industry Opportunities and Challenges
- 2.4 Steroids Industry Restraints
3 Steroids Market by Manufacturers
- 3.1 Global Steroids Revenue by Manufacturers (2021-2026)
- 3.2 Global Steroids Sales by Manufacturers (2021-2026)
- 3.3 Global Steroids Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Steroids Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Steroids Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Steroids Manufacturers, Product Type & Application
- 3.7 Global Steroids Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Steroids Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Steroids Players Market Share by Revenue in 2025
- 3.8.3 2025 Steroids Tier 1, Tier 2, and Tier 3
4 Steroids Market by Type
- 4.1 Steroids Type Introduction
- 4.1.1 Corticosteroids
- 4.1.2 Sex Hormones
- 4.2 Global Steroids Sales by Type
- 4.2.1 Global Steroids Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Steroids Sales by Type (2021-2032)
- 4.2.3 Global Steroids Sales Market Share by Type (2021-2032)
- 4.3 Global Steroids Revenue by Type
- 4.3.1 Global Steroids Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Steroids Revenue by Type (2021-2032)
- 4.3.3 Global Steroids Revenue Market Share by Type (2021-2032)
5 Steroids Market by Application
- 5.1 Steroids Application Introduction
- 5.1.1 Injection
- 5.1.2 Inhalation
- 5.1.3 Oral
- 5.1.4 Topical
- 5.2 Global Steroids Sales by Application
- 5.2.1 Global Steroids Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Steroids Sales by Application (2021-2032)
- 5.2.3 Global Steroids Sales Market Share by Application (2021-2032)
- 5.3 Global Steroids Revenue by Application
- 5.3.1 Global Steroids Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Steroids Revenue by Application (2021-2032)
- 5.3.3 Global Steroids Revenue Market Share by Application (2021-2032)
6 Global Steroids Sales by Region
- 6.1 Global Steroids Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Steroids Sales by Region (2021-2032)
- 6.2.1 Global Steroids Sales by Region (2021-2026)
- 6.2.2 Global Steroids Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Steroids Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Steroids Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Steroids Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Steroids Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Steroids Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Steroids Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Steroids Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Steroids Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Steroids Revenue by Region
- 7.1 Global Steroids Revenue by Region
- 7.1.1 Global Steroids Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Steroids Revenue by Region (2021-2026)
- 7.1.3 Global Steroids Revenue by Region (2027-2032)
- 7.1.4 Global Steroids Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Steroids Revenue (2021-2032)
- 7.2.2 North America Steroids Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Steroids Revenue (2021-2032)
- 7.3.2 Europe Steroids Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Steroids Revenue (2021-2032)
- 7.4.2 Asia-Pacific Steroids Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Steroids Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Steroids Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Zizhu Pharma
- 8.1.1 Zizhu Pharma Company Information
- 8.1.2 Zizhu Pharma Business Overview
- 8.1.3 Zizhu Pharma Steroids Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Zizhu Pharma Steroids Product Portfolio
- 8.1.5 Zizhu Pharma Recent Developments
- 8.2 Sanofi
- 8.2.1 Sanofi Company Information
- 8.2.2 Sanofi Business Overview
- 8.2.3 Sanofi Steroids Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Sanofi Steroids Product Portfolio
- 8.2.5 Sanofi Recent Developments
- 8.3 Novartis
- 8.3.1 Novartis Company Information
- 8.3.2 Novartis Business Overview
- 8.3.3 Novartis Steroids Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Novartis Steroids Product Portfolio
- 8.3.5 Novartis Recent Developments
- 8.4 Merck
- 8.4.1 Merck Company Information
- 8.4.2 Merck Business Overview
- 8.4.3 Merck Steroids Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Merck Steroids Product Portfolio
- 8.4.5 Merck Recent Developments
- 8.5 Pfizer
- 8.5.1 Pfizer Company Information
- 8.5.2 Pfizer Business Overview
- 8.5.3 Pfizer Steroids Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Pfizer Steroids Product Portfolio
- 8.5.5 Pfizer Recent Developments
- 8.6 GSK
- 8.6.1 GSK Company Information
- 8.6.2 GSK Business Overview
- 8.6.3 GSK Steroids Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 GSK Steroids Product Portfolio
- 8.6.5 GSK Recent Developments
- 8.7 Bayer
- 8.7.1 Bayer Company Information
- 8.7.2 Bayer Business Overview
- 8.7.3 Bayer Steroids Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Bayer Steroids Product Portfolio
- 8.7.5 Bayer Recent Developments
- 8.8 AstraZeneca
- 8.8.1 AstraZeneca Company Information
- 8.8.2 AstraZeneca Business Overview
- 8.8.3 AstraZeneca Steroids Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 AstraZeneca Steroids Product Portfolio
- 8.8.5 AstraZeneca Recent Developments
- 8.9 Sumitomo
- 8.9.1 Sumitomo Company Information
- 8.9.2 Sumitomo Business Overview
- 8.9.3 Sumitomo Steroids Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Sumitomo Steroids Product Portfolio
- 8.9.5 Sumitomo Recent Developments
- 8.10 Cipla
- 8.10.1 Cipla Company Information
- 8.10.2 Cipla Business Overview
- 8.10.3 Cipla Steroids Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Cipla Steroids Product Portfolio
- 8.10.5 Cipla Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Steroids Value Chain Analysis
- 9.1.1 Steroids Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Steroids Production Mode & Process
- 9.2 Steroids Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Steroids Distributors
- 9.2.3 Steroids Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst